Susan K Lutgendorf1,2,3,4, Premal H Thaker5, Jesusa M Arevalo6,7, Michael J Goodheart2,4, George M Slavich7,8, Anil K Sood9,10,11, Steve W Cole6,7,8. 1. Department of Psychological and Brain Sciences, University of Iowa, Iowa City, Iowa. 2. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa. 3. Department of Urology, University of Iowa, Iowa City, Iowa. 4. Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa. 5. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri. 6. Division of Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, California. 7. Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, California. 8. Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California. 9. Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 10. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 11. Center for RNA Interference and Noncoding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract
BACKGROUND: Social factors in the patient macroenvironment have been shown to influence molecular events in the tumor microenvironment and thereby influence cancer progression. However, biomarkers providing a window into the longitudinal effects of biobehavioral factors on tumor biology over time are lacking. Exosome analysis is a novel strategy for in vivo monitoring of dynamic changes in tumor cells. This study examined exosomal profiles from patients with low or high levels of social support for epithelial-mesenchymal transition (EMT) polarization and gene expression related to inflammation and β-adrenergic signaling. METHODS: Exosomes were isolated from plasma sampled from a series of 40 women before primary surgical resection of advanced-stage, high-grade ovarian carcinoma. Samples were selected for analysis on the basis of extremes of low and high levels of social support. After exosomal isolation and RNA extraction, a microarray analysis of the transcriptome was performed. RESULTS: Primary analyses identified significant upregulation of 67 mesenchymal-characteristic gene transcripts and downregulation of 63 epithelial-characteristic transcripts in patients with low social support; this demonstrated increased EMT polarization (P = .0002). Secondary analyses using promoter sequence bioinformatics supported a priori hypotheses linking low social support to 1) increased activity of cyclic adenosine monophosphate response element binding protein (CREB)/activating transcription factor (ATF) family transcription factors that mediate the β-adrenergic response to catecholamines via the cyclic adenosine monophosphate/protein kinase A signaling pathway (mean fold change for CREB: 2.24 ± 0.65; P = .0019; mean fold change for ATF: 2.00 ± 0.55; P = .0049) and 2) increased activity of the proinflammatory nuclear factor κB/Rel family of transcription factors (mean fold change: 2.10 ± 0.70; P = .0109). CONCLUSIONS: These findings suggest the possibility of leveraging exosomes as a noninvasive assessment of biobehavioral factors to help to direct personalized treatment approaches. Cancer 2018;124:580-6.
BACKGROUND: Social factors in the patient macroenvironment have been shown to influence molecular events in the tumor microenvironment and thereby influence cancer progression. However, biomarkers providing a window into the longitudinal effects of biobehavioral factors on tumor biology over time are lacking. Exosome analysis is a novel strategy for in vivo monitoring of dynamic changes in tumor cells. This study examined exosomal profiles from patients with low or high levels of social support for epithelial-mesenchymal transition (EMT) polarization and gene expression related to inflammation and β-adrenergic signaling. METHODS: Exosomes were isolated from plasma sampled from a series of 40 women before primary surgical resection of advanced-stage, high-grade ovarian carcinoma. Samples were selected for analysis on the basis of extremes of low and high levels of social support. After exosomal isolation and RNA extraction, a microarray analysis of the transcriptome was performed. RESULTS: Primary analyses identified significant upregulation of 67 mesenchymal-characteristic gene transcripts and downregulation of 63 epithelial-characteristic transcripts in patients with low social support; this demonstrated increased EMT polarization (P = .0002). Secondary analyses using promoter sequence bioinformatics supported a priori hypotheses linking low social support to 1) increased activity of cyclic adenosine monophosphate response element binding protein (CREB)/activating transcription factor (ATF) family transcription factors that mediate the β-adrenergic response to catecholamines via the cyclic adenosine monophosphate/protein kinase A signaling pathway (mean fold change for CREB: 2.24 ± 0.65; P = .0019; mean fold change for ATF: 2.00 ± 0.55; P = .0049) and 2) increased activity of the proinflammatory nuclear factor κB/Rel family of transcription factors (mean fold change: 2.10 ± 0.70; P = .0109). CONCLUSIONS: These findings suggest the possibility of leveraging exosomes as a noninvasive assessment of biobehavioral factors to help to direct personalized treatment approaches. Cancer 2018;124:580-6.
Authors: Susan K Lutgendorf; Koen DeGeest; Laila Dahmoush; Donna Farley; Frank Penedo; David Bender; Michael Goodheart; Thomas E Buekers; Luis Mendez; Gina Krueger; Lauren Clevenger; David M Lubaroff; Anil K Sood; Steve W Cole Journal: Brain Behav Immun Date: 2010-10-16 Impact factor: 7.217
Authors: Susan K Lutgendorf; Donald M Lamkin; Nicholas B Jennings; Jesusa M G Arevalo; Frank Penedo; Koen DeGeest; Robert R Langley; Joseph A Lucci; Steve W Cole; David M Lubaroff; Anil K Sood Journal: Clin Cancer Res Date: 2008-11-01 Impact factor: 12.531
Authors: Lorenzo Cohen; Steven W Cole; Anil K Sood; Sarah Prinsloo; Clemens Kirschbaum; Jesusa M G Arevalo; Nicholas B Jennings; Shellie Scott; Luis Vence; Qi Wei; Diane Kentor; Laszlo Radvanyi; Nizar Tannir; Eric Jonasch; Pheroze Tamboli; Louis Pisters Journal: PLoS One Date: 2012-08-01 Impact factor: 3.240
Authors: Valeriy Domenyuk; Zhenyu Zhong; Adam Stark; Nianqing Xiao; Heather A O'Neill; Xixi Wei; Jie Wang; Teresa T Tinder; Sonal Tonapi; Janet Duncan; Tassilo Hornung; Andrew Hunter; Mark R Miglarese; Joachim Schorr; David D Halbert; John Quackenbush; George Poste; Donald A Berry; Günter Mayer; Michael Famulok; David Spetzler Journal: Sci Rep Date: 2017-02-20 Impact factor: 4.379
Authors: G Scambia; U Testa; P Benedetti Panici; E Foti; R Martucci; A Gadducci; A Perillo; V Facchini; C Peschle; S Mancuso Journal: Br J Cancer Date: 1995-02 Impact factor: 7.640
Authors: Claudia Trudel-Fitzgerald; Elizabeth M Poole; Anil K Sood; Olivia I Okereke; Ichiro Kawachi; Laura D Kubzansky; Shelley S Tworoger Journal: Psychosom Med Date: 2019 Nov/Dec Impact factor: 4.312
Authors: Jennifer M Knight; Mallory R Taylor; Kelly E Rentscher; Elisabeth C Henley; Hannah A Uttley; Ashley M Nelson; Lucie M Turcotte; Natalie S McAndrew; Hermioni L Amonoo; Lathika Mohanraj; Debra Lynch Kelly; Erin S Costanzo Journal: Front Immunol Date: 2022-07-05 Impact factor: 8.786
Authors: Susan K Lutgendorf; Frank Penedo; Michael J Goodheart; Laila Dahmoush; Jesusa M G Arevalo; Premal H Thaker; George M Slavich; Anil K Sood; Steve W Cole Journal: Cancer Date: 2020-07-21 Impact factor: 6.860
Authors: Snehal Bindra; Marlon A McGill; Marina K Triplett; Anisha Tyagi; Premal H Thaker; Laila Dahmoush; Michael J Goodheart; R Todd Ogden; Edward Owusu-Ansah; Kalpita R Karan; Steve Cole; Anil K Sood; Susan K Lutgendorf; Martin Picard Journal: Sci Rep Date: 2021-06-02 Impact factor: 4.996
Authors: E M Hummel; E Hessas; S Müller; T Beiter; M Fisch; A Eibl; O T Wolf; B Giebel; P Platen; R Kumsta; D A Moser Journal: Transl Psychiatry Date: 2018-10-29 Impact factor: 6.222
Authors: Guanxi Qiao; Mark J Bucsek; Nicolette M Winder; Minhui Chen; Thejaswini Giridharan; Scott H Olejniczak; Bonnie L Hylander; Elizabeth A Repasky Journal: Cancer Immunol Immunother Date: 2018-09-18 Impact factor: 6.630